Page last updated: 2024-08-17

nadp and Cancer of Prostate

nadp has been researched along with Cancer of Prostate in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-199013 (54.17)18.7374
1990's4 (16.67)18.2507
2000's1 (4.17)29.6817
2010's5 (20.83)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Cao, R; Periasamy, A; Wallrabe, H1
Huang, S; Ma, Y; Wang, S; Yang, Y; Yang, Z1
Chen, HW; Hung, CL; Kung, HJ; Petrovics, G; Srivastava, S; Wang, LY; Yu, YL1
Bost, F; Djabari, Z; Goiran, T; Laurent, K; Loubière, C; Tanti, JF1
Cavallini, L; Chiarugi, P; Giannoni, E; Ippolito, L; Marini, A; Morandi, A; Pietrovito, L; Pintus, G; Puhr, M; Schrader, T; Taddei, ML1
Benfodda, Z; Carbonneau, MA; Casas, F; Cristol, JP; Fajas, L; Fritz, V; Henriquet, C; Hure, S; Michel, F1
KISER, WS; RIGGINS, RS1
Aizawa, Y; Akiyama, Y; Goda, R; Ikemoto, I; Nagai, D; Nagata, K; Nishikawa, K; Yamazoe, Y1
Bruchovsky, N; McLoughlin, MG; Rennie, PS; To, MP1
Hudson, RW; Moffitt, PM; Owens, WA1
Oshima, H; Troen, P; Yoshida, KI1
Lack, L; Petrow, V; Sandberg, A; Wang, Y1
Lack, L; Petrow, V1
Coene, MC; Cools, W; Janssens, B; Krekels, MD; Van Ginckel, R; Van Hove, C; Wouters, W; Zimmerman, J1
Jacobi, GH; Wilson, JD1
Charles, JF; Floch, HH; Morfin, RF1
Liang, T; Liao, S1
Hudson, RW; Wherrett, D1
Jutley, JK; Kelleher, J; Reaney, S; Whelan, P1
Bailyes, E; Cooper, EH; Johannsson, A; Moss, DW; Self, CH; Siddle, K; Stanley, CJ; Whitaker, KB1
Halgunset, J; Lundmo, PI; Sunde, A1
Hilf, R; Miller, HC; Rector, W1
Ochiai, K; Oshima, H; Sarada, T; Tamaoki, B1
Baillie, AH; Mack, WS1

Other Studies

24 other study(ies) available for nadp and Cancer of Prostate

ArticleYear
Multiphoton FLIM imaging of NAD(P)H and FAD with one excitation wavelength.
    Journal of biomedical optics, 2020, Volume: 25, Issue:1

    Topics: Antibiotics, Antineoplastic; Doxorubicin; Flavin-Adenine Dinucleotide; Fluorescence; Humans; Male; Microscopy, Fluorescence, Multiphoton; NADP; Photons; Prostatic Neoplasms; Tumor Cells, Cultured

2020
miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in Prostate Cancer Cells.
    DNA and cell biology, 2017, Volume: 36, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cell Line, Tumor; Cisplatin; DNA Damage; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; Humans; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; NADP; Phosphoric Monoester Hydrolases; Prostatic Neoplasms

2017
A long noncoding RNA connects c-Myc to tumor metabolism.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Dec-30, Volume: 111, Issue:52

    Topics: Aerobiosis; Cell Line, Tumor; Glycolysis; HEK293 Cells; Humans; Male; NADP; Pentose Phosphate Pathway; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myc; Receptors, Androgen; RNA, Long Noncoding; RNA, Neoplasm

2014
Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.
    Oncotarget, 2015, Jun-20, Volume: 6, Issue:17

    Topics: Acetyl-CoA Carboxylase; Adenosine Triphosphate; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Fatty Acid Synthase, Type I; Humans; Lipogenesis; Male; Malonyl Coenzyme A; Metformin; NADP; Prostate; Prostatic Neoplasms; Sterol Regulatory Element Binding Protein 1

2015
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
    Oncotarget, 2016, 09-20, Volume: 7, Issue:38

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coculture Techniques; Docetaxel; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Fibroblasts; Glucose; Glutamine; Glycolysis; Humans; Male; Mitochondria; NADP; Oxidative Phosphorylation; Phenotype; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Taxoids

2016
Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth.
    Oncogene, 2013, Oct-17, Volume: 32, Issue:42

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Humans; Male; Malonyl Coenzyme A; Mice, Nude; Molecular Targeted Therapy; NADP; NADPH Oxidases; Oxidative Stress; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2013
LACTIC DEHYDROGENASE ISOZYMES IN URINE.
    Investigative urology, 1964, Volume: 2

    Topics: Chromatography; Cystitis; Electrophoresis; Humans; Isoenzymes; Kidney Calculi; Kidney Diseases; Kidney Neoplasms; L-Lactate Dehydrogenase; Male; NADP; Nephrosis; Prostatic Hyperplasia; Prostatic Neoplasms; Pyelonephritis; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urine; Urology

1964
Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients.
    Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:5

    Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Flutamide; Humans; Indicators and Reagents; Male; Microsomes, Liver; NADP; Prostatic Neoplasms; Spectrometry, Mass, Electrospray Ionization

2006
Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
    Progress in clinical and biological research, 1981, Volume: 75A

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Aged; Dihydrotestosterone; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; NADP; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1981
Studies of the nuclear 5 alpha-reductase of human prostatic tissue: comparison of enzyme activities in hyperplastic, malignant, and normal tissues.
    Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire, 1983, Volume: 61, Issue:7

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Acid Phosphatase; Dihydrotestosterone; Humans; Male; NADP; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Tissue Distribution

1983
Studies of the human testis. XIII. Properties of nicotinamide adenine dinucleotide (reduced form)-linked 17 alpha-hydroxylation.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 50, Issue:5

    Topics: Carbon Monoxide; Humans; Kinetics; Male; Microsomes; NAD; NADP; Oxidation-Reduction; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases; Testis

1980
Prostatic cancer. I. 6-Methylene-4-pregnen-3-ones as irreversible inhibitors of rat prostatic delta 4-3 ketosteroid 5 alpha-reductase.
    Steroids, 1981, Volume: 38, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Animals; Kinetics; Male; NADP; Oxidoreductases; Progesterone; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testosterone

1981
Studies on a 5 alpha-reductase inhibitor and their therapeutic implications.
    Progress in clinical and biological research, 1981, Volume: 75B

    Topics: 5-alpha Reductase Inhibitors; Animals; Antineoplastic Agents; Cell Nucleus; Chemical Phenomena; Chemistry, Physical; Humans; In Vitro Techniques; Kinetics; Male; NADP; Oxidoreductases; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Testosterone; Time Factors

1981
Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors.
    The Prostate, 1996, Volume: 29, Issue:1

    Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Imidazoles; Kinetics; Liver; Male; NADP; Oxidation-Reduction; Prostatic Neoplasms; Rats; Rats, Wistar; Tretinoin

1996
Formation of 5alpha-androstane-3alpha,17beta-diol by normal and hypertrophic human prostate.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:1

    Topics: Adult; Age Factors; Aged; Androstane-3,17-diol; Androstanes; Cytosol; Dihydrotestosterone; Female; Humans; Male; Microsomes; Middle Aged; NAD; NADP; Organ Size; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Time Factors

1977
C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
    Journal of steroid biochemistry, 1979, Volume: 11, Issue:1B

    Topics: Androstane-3,17-diol; Androstanols; Dihydrotestosterone; Humans; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Male; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1979
Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
    The Biochemical journal, 1992, Jul-15, Volume: 285 ( Pt 2)

    Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Azasteroids; Dihydrotestosterone; Fatty Acids, Unsaturated; Female; Humans; Male; Microscopy, Electron; Microsomes, Liver; NADP; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testosterone; Tumor Cells, Cultured

1992
Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
    Journal of steroid biochemistry, 1990, Volume: 35, Issue:2

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Cell Fractionation; Cell Nucleus; Humans; Kinetics; Male; NADP; Oxidation-Reduction; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1990
Interactions of retinoic acid and androgens in human prostatic tissue.
    The Prostate, 1990, Volume: 16, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Carrier Proteins; Humans; Male; NADP; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Retinoic Acid; Tretinoin

1990
An enzyme-amplified monoclonal immunoenzymometric assay for prostatic acid phosphatase.
    Clinica chimica acta; international journal of clinical chemistry, 1985, Oct-31, Volume: 152, Issue:1-2

    Topics: Acid Phosphatase; Antibodies, Monoclonal; Cross Reactions; Epitopes; Humans; Immunoenzyme Techniques; Isoenzymes; Male; Methods; NAD; NADP; Prostate; Prostatic Neoplasms; Reference Values

1985
Retinoic acid (RA): an inhibitor of 5 alpha-reductase in human prostatic cancer cells.
    Journal of steroid biochemistry, 1987, Volume: 28, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Dose-Response Relationship, Drug; Humans; Male; NADP; Prostatic Neoplasms; Tretinoin; Tumor Cells, Cultured

1987
Preliminary enzymatic studies of human benign prostate hypertrophy and prostatic cancer.
    Investigative urology, 1972, Volume: 10, Issue:1

    Topics: Adenocarcinoma; Diethylstilbestrol; Glucose-6-Phosphate Isomerase; Glucosephosphate Dehydrogenase; Humans; L-Lactate Dehydrogenase; Lymph Nodes; Male; NADP; Prostatic Hyperplasia; Prostatic Neoplasms; Pyruvate Kinase

1972
Effects of a synthetic estrogen upon steroid bioconversion in vitro in testes of patients with prostatic cancer.
    Investigative urology, 1974, Volume: 12, Issue:1

    Topics: 17-alpha-Hydroxypregnenolone; Administration, Oral; Aged; Androstenedione; Enzyme Repression; Hexestrol; Humans; Hydroxyprogesterones; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Isomerases; Lyases; Male; Middle Aged; Mixed Function Oxygenases; NADP; Progesterone; Prostatic Neoplasms; Spermatogenesis; Steroids; Testis; Testosterone

1974
Hydroxysteroid dehydrogenases in normal and abnormal human testes.
    The Journal of endocrinology, 1966, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Aged; Androgens; Child; Cryptorchidism; Dehydroepiandrosterone; Hernia, Inguinal; Histocytochemistry; Humans; Hydroxysteroid Dehydrogenases; Leydig Cells; Male; Middle Aged; NAD; NADP; Prostatic Neoplasms; Spermatic Cord Torsion; Testis

1966